Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
NVCT on Nasdaq
Matthew Kaplan - trading volume in the past year for Nuvectis Pharma, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
124,760 |
$728,598 |
$5.84 |
05 Nov 2025 |
Direct |
|
|
Transactions reported by Matthew Kaplan for Nuvectis Pharma, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.